Ada Sala-Hojman is an author at Merck (Germany).
Publications per year
2014–2023
4
4
Active CREB1 Promotes a Malignant TGFβ2 Autocrine Loop in Glioblastoma
Laura Rodón, Alba Gonzàlez-Juncà, María del Mar Inda et al. · Cancer Discovery · 2014 · 76 citations · Full text
MCT4 blockade increases the efficacy of immune checkpoint blockade
Nathalie Babl, Sonja-Maria Decking, Florian Voll et al. · Journal for ImmunoTherapy of Cancer · 2023 · 74 citations · Full text
Timo Heinrich, Ada Sala-Hojman, Roberta Ferretti et al. · Journal of Medicinal Chemistry · 2021 · 19 citations · Full text
Rows per page
1–4 of 4